Sun, Nov 24, 2024
Volume 12, Issue 1 (Jan-Feb 2018)
mljgoums 2018, 12(1): 1-5 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Vahed Jabbari M, Abolfathi A. Evaluation of Relationship between Serum Levels of Inflammatory Factors and Clinical Symptoms in Females with Knee Osteoarthritis . mljgoums 2018; 12 (1) :1-5
URL: http://mlj.goums.ac.ir/article-1-1036-en.html
URL: http://mlj.goums.ac.ir/article-1-1036-en.html
1- Department of Biology, Islamic Azad University, Ahar branch, Ahar, Iran
2- Department of Biology, Ahar branch, Islamic Azad university, Ahar, Iran ,Abolfathi.Aliakbar@gmail.com
2- Department of Biology, Ahar branch, Islamic Azad university, Ahar, Iran ,
Abstract: (17184 Views)
ABSTRACT
Background and Objectives: Osteoarthritis (OS) is the most common type of arthritis and joint disease, especially in women. Proinflammatory cytokines, biochemical factors, specially matrix metalloproteinases, and reactive oxygen species play important roles in joint destruction in this disease. Therefore, the present study aimed to evaluate level of inflammatory factors and its relationship with clinical symptoms of OS in female patients.
Methods: The study was performed on female patients with knee OS, referring to healthcare centers of Tabriz University of Medical Sciences. After measuring the weight and height of patients, clinical symptoms such as severity of pain and physical performance were evaluated using the Knee Injury and Osteopaedic Outcome Score questionnaire. Serum levels of IL-1β, TNF-α, and hs-CRP in fasting blood samples were measured using ELISA kits and immunoturbidimetric assays.
Results: There was a significant association between level of IL-1β and score of pain. There was no significant relationship between the clinical symptoms and level of other inflammatory factors.
Conclusion: The results of the present study showed that the increase in inflammatory factors is correlated with severity of pain in OS patients.
Keywords: Osteoarthritis Knee, Female, Inflammatory Markers.
Background and Objectives: Osteoarthritis (OS) is the most common type of arthritis and joint disease, especially in women. Proinflammatory cytokines, biochemical factors, specially matrix metalloproteinases, and reactive oxygen species play important roles in joint destruction in this disease. Therefore, the present study aimed to evaluate level of inflammatory factors and its relationship with clinical symptoms of OS in female patients.
Methods: The study was performed on female patients with knee OS, referring to healthcare centers of Tabriz University of Medical Sciences. After measuring the weight and height of patients, clinical symptoms such as severity of pain and physical performance were evaluated using the Knee Injury and Osteopaedic Outcome Score questionnaire. Serum levels of IL-1β, TNF-α, and hs-CRP in fasting blood samples were measured using ELISA kits and immunoturbidimetric assays.
Results: There was a significant association between level of IL-1β and score of pain. There was no significant relationship between the clinical symptoms and level of other inflammatory factors.
Conclusion: The results of the present study showed that the increase in inflammatory factors is correlated with severity of pain in OS patients.
Keywords: Osteoarthritis Knee, Female, Inflammatory Markers.
Research Article: Original Paper |
Received: 2018/01/21 | Accepted: 2018/01/21 | Published: 2018/01/21 | ePublished: 2018/01/21
Received: 2018/01/21 | Accepted: 2018/01/21 | Published: 2018/01/21 | ePublished: 2018/01/21
References
1. Song SY, Han YD, Hong SY, Kim K, Yang SS, Min B-H, et al. Chip-based cartilage oligomeric matrix protein detection in serum and synovial fluid for osteoarthritis diagnosis. Analytical biochemistry. 2012; 420(2): 139-46. doi: 10.1016/j.ab.2011.09.012. [DOI:10.1016/j.ab.2011.09.012]
2. Sharif M, Shepstone L, Elson C, Dieppe P, Kirwan J. Increased serum C reactive protein may reflect events that precede radiographic progression in osteoarthritis of the knee. Annals of the rheumatic diseases. 2000; 59(1): 71-4. [DOI:10.1136/ard.59.1.71]
3. Sanghi D, Mishra A, Singh A, Srivastava RN, Avasthi S, Agarwal S. Is radiology a determinant of pain, stiffness, and functional disability in knee osteoarthritis? A cross-sectional study. Journal of Orthopaedic Science. 2011; 16(6): 719-25. doi: 10.1007/s00776-011-0147-y. [DOI:10.1007/s00776-011-0147-y]
4. Phillips CR, Brasington Jr RD. Osteoarthritis treatment update: Are NSAIDs still in the picture? These agents are the most effective, but the risks may outweigh the benefits. The Journal of Musculoskeletal Medicine. 2010; 27(2): 65-72.
5. Pelletier J, Martel-Pelletier J. Evidence for the involvement of interleukin 1 in human osteoarthritic cartilage degradation: protective effect of NSAID. The Journal of rheumatology Supplement. 1989; 18: 19-27.
6. Pearle A, Scanzello C, George S, Mandl LA, DiCarlo E, Peterson M, et al. Elevated high-sensitivity C-reactive protein levels are associated with local inflammatory findings in patients with osteoarthritis. Osteoarthritis and Cartilage. 2007; 15(5): 516-23. [DOI:10.1016/j.joca.2006.10.010]
7. Nikniaz Z, Ostadrahimi A, Mahdavi R, asghar Ebrahimi A, Nikniaz L. Effects of Elaeagnus angustifolia L. supplementation on serum levels of inflammatory cytokines and matrix metalloproteinases in females with knee osteoarthritis. Complementary therapies in medicine. 2014; 22(5): 864-9. DOI:10.1016/j.ctim.2014.07.004. [DOI:10.1016/j.ctim.2014.07.004]
8. Martel-Pelletier J. Pathophysiology of osteoarthritis. Osteoarthritis and cartilage. 1998; 6(6): 374-6. DOI: http://dx.doi.org/10.1016/j.joca.2003.10.002. [DOI:10.1016/j.joca.2003.10.002]
9. Malek Mahdavi A, Mahdavi R, Kolahi S. Effects of l-Carnitine Supplementation on Serum Inflammatory Factors and Matrix Metalloproteinase Enzymes in Females with Knee Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled Pilot Study. Journal of the American College of Nutrition. 2016: 35(7):597-603. DOI:10.1080/07315724.2015.1068139. [DOI:10.1080/07315724.2015.1068139]
10. Lussier A, Cividino A, McFarlane C, Olszynski W, Potashner W, De Medicis R. Viscosupplementation with hylan for the treatment of osteoarthritis: findings from clinical practice in Canada. The Journal of rheumatology. 1996; 23(9): 1579-85.
11. Lange AK, Vanwanseele B. Strength training for treatment of osteoarthritis of the knee: a systematic review. Arthritis Care & Research. 2008; 59(10): 1488-94. doi: 10.1002/art.24118. [DOI:10.1002/art.24118]
12. Kolahi S, Mahdavi AM, Mahdavi R, Lak S. Effect of l-carnitine supplementation on clinical symptoms in women with osteoarthritis of the knee: A randomized, double-blind, placebo-controlled trial. European Journal of Integrative Medicine. 2015;7(5):540-6. DOI: 10.1016/j.eujim.2015.04.001. [DOI:10.1016/j.eujim.2015.04.001]
13. Kapoor M, Martel-Pelletier J, Lajeunesse D, Pelletier J-P, Fahmi H. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nature Reviews Rheumatology. 2011; 7(1): 33-42. doi: 10.1038/nrrheum.2010.196. [DOI:10.1038/nrrheum.2010.196]
14. Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: part I. Arthritis Rheum. 2008; 58:15-25. doi: 10.1002/art.23177. [DOI:10.1002/art.23177]
15. Imamura M, Targino RA, Hsing WT, Imamura S, Azevedo RS, Boas LSV, et al. Concentration of cytokines in patients with osteoarthritis of the knee and fibromyalgia. Clinical interventions in aging. 2014; 9: 939-44. doi: 10.2147/CIA.S60330. [DOI:10.2147/CIA.S60330]
16. Hussein MR, Fathi NA, El-Din AME, Hassan HI, Abdullah F, Eman A-H, et al. Alterations of the CD4+, CD8+ T cell subsets, interleukins-1β, IL-10, IL-17, tumor necrosis factor-α and soluble intercellular adhesion molecule-1 in rheumatoid arthritis and osteoarthritis: preliminary observations. Pathology & Oncology Research. 2008; 14(3): 321-8. [DOI:10.1007/s12253-008-9016-1]
17. Hunter DJ. In the clinic. Osteoarthritis. Annals of internal medicine. 2007; 147(3): ITC8-1-ITC8-16.
18. Geba GP, Weaver AL, Polis AB, Dixon ME, Schnitzer TJ, Group V. Efficacy of rofecoxib, celecoxib, and acetaminophen in osteoarthritis of the knee: a randomized trial. Jama. 2002; 287(1): 64-71. [DOI:10.1001/jama.287.1.64]
19. Foley A, Halbert J, Hewitt T, Crotty M. Does hydrotherapy improve strength and physical function in patients with osteoarthritis—a randomised controlled trial comparing a gym based and a hydrotherapy based strengthening programme. Annals of the rheumatic diseases. 2003; 62(12):1162-7. doi: 10.1136/ard.2002.005272. [DOI:10.1136/ard.2002.005272]
20. Fernandes JC, Martel‐Pelletier J, Pelletier JP. The role of cytokines in osteoarthritis pathophysiology. Biorheology. 2002; 39(1, 2): 237-46.
21. El-barbary AM, Khalek MAA, Elsalawy AM, Hazaa SM. Assessment of lipid peroxidation and antioxidant status in rheumatoid arthritis and osteoarthritis patients. The Egyptian Rheumatologist. 2011; 33(4): 179-85. [DOI:10.1016/j.ejr.2011.07.002]
22. El-Arman MM, El-Fayoumi G, El-Shal E, El-Boghdady I, El-Ghaweet A. Aggrecan and cartilage oligomeric matrix protein in serum and synovial fluid of patients with knee osteoarthritis. HSS journal. 2010; 6(2): 171-6. doi: 10.1007/s11420-010-9157-0.Conrozier T, Carlier M, Mathieu P, Colson F, Debard A, Richard S, et al. Serum levels of YKL-40 and C reactive protein in patients with hip osteoarthritis and healthy subjects: a cross sectional study. Annals of the rheumatic diseases. 2000; 59(10): 828-31. [DOI:10.1136/ard.59.10.828]
23. Christensen R, Astrup A, Bliddal H. Weight loss: the treatment of choice for knee osteoarthritis? A randomized trial. Osteoarthritis and Cartilage. 2005; 13(1): 20-7. [DOI:10.1016/j.joca.2004.10.008]
24. Case JP, Baliunas AJ, Block JA. Lack of efficacy of acetaminophen in treating symptomatic knee osteoarthritis: a randomized, double-blind, placebo-controlled comparison trial with diclofenac sodium. Archives of Internal Medicine. 2003; 163(2): 169-78. [DOI:10.1001/archinte.163.2.169]
25. Buckwalter JA, Saltzman C, Brown T. The impact of osteoarthritis: implications for research. Clinical orthopaedics and related research. 2004; 427: S6-S15. [DOI:10.1097/01.blo.0000143938.30681.9d]
26. Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, et al. International physical activity questionnaire: 12-country reliability and validity. Med sci sports Exerc. 2003; 195(9131/03): 3508-1381.
27. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. The Journal of rheumatology. 1988; 15(12): 1833-40.
28. Alcaraz MJ, Megías J, García-Arnandis I, Clérigues V, Guillén MI. New molecular targets for the treatment of osteoarthritis. Biochemical pharmacology. 2010; 80(1): 13-21. doi: 10.1016/j.bcp.2010.02.017. [DOI:10.1016/j.bcp.2010.02.017]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Enamad
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.